Aqr Arbitrage LLC Sage Therapeutics, Inc. Transaction History
Aqr Arbitrage LLC
- $1.52 Billion
- Q2 2025
A detailed history of Aqr Arbitrage LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Aqr Arbitrage LLC holds 409,055 shares of SAGE stock, worth $3.55 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
409,055Holding current value
$3.55 Million% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding SAGE
# of Institutions
168Shares Held
44.3MCall Options Held
790KPut Options Held
440K-
Madison Avenue Partners, LP New York, NY6.08MShares$52.7 Million5.93% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$45.3 Million0.0% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT1.95MShares$16.9 Million0.07% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.92MShares$16.6 Million0.01% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.52MShares$13.2 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $516M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...